Inventor · disambiguated record
John Kulman
Also filed as: KULMAN JOHN · KULMAN JOHN D
18 granted patents·35 pending applications·196 citations·filing 2012–2025
94Inventor score
Files withBIOVERATIV THERAPEUTICS INC21CODIAK BIOSCIENCES INC9CRISPR THERAPEUTICS AG7LONZA SALES AG7BIOGEN MA INC4
Top patents by PatentIndex Score
53 records- 0195US10195290B1Preparation of therapeutic exosomes using membrane proteinsCODIAK BIOSCIENCES INC·Filed 2018·Granted Feb 5, 2019·88 cites·20 claims
- 0294US10561740B2Preparation of therapeutic exosomes using membrane proteinsCODIAK BIOSCIENCES INC·Filed 2018·Granted Feb 18, 2020·12 cites·15 claims
- 0394US10138291B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Nov 27, 2018·30 cites·36 claims
- 0493US11192936B2Factor VIII chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2015·Granted Dec 7, 2021·10 cites·58 claims
- 0593US11091534B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Aug 17, 2021·8 cites·20 claims
- 0693US10723782B2Exosomes for immuno-oncology and anti-inflammatory therapyCODIAK BIOSCIENCES INC·Filed 2018·Granted Jul 28, 2020·9 cites·19 claims
- 0791US12331100B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2022·Granted Jun 17, 2025·1 cites·20 claims
- 0891US12257313B2Preparation of therapeutic exosomes using membrane proteinsLONZA SALES AG·Filed 2022·Granted Mar 25, 2025·1 cites·19 claims
- 0991US10421798B2Factor VIII compositions and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2012·Granted Sep 24, 2019·16 cites·44 claims
- 1089US10745680B2Factor IX fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Aug 18, 2020·6 cites·27 claims
- 1189US10548953B2Factor VIII-XTEN fusions and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Feb 4, 2020·6 cites·17 claims
- 1288US11679164B2Preparation of therapeutic exosomes using membrane proteinsCODIAK BIOSCIENCES INC·Filed 2019·Granted Jun 20, 2023·3 cites·20 claims
- 1383US12030924B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2020·Granted Jul 9, 2024·1 cites·18 claims
- 1482US2025144183A1Methods and compositions for treating lipoprotein-related diseasesCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 1582US2025011771A1Methods and compositions for treating lipoprotein-related diseasesCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 1681US2025011743A1Methods and compositions for treating angiopoietin-like 3 (angptl3) related conditionsCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 1781US2025043261A1Methods and compositions for treating angiopoietin-like 3 (angptl3) related conditionsCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 1880US12037616B2Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditionsCRISPR THERAPEUTICS AG·Filed 2023·Granted Jul 16, 2024·0 cites·20 claims
- 1978US10370430B2Recombinant factor VIII proteinsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Aug 6, 2019·3 cites·20 claims
- 2077US2025296980A1Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2025·Application pending·0 cites
- 2176US12158424B2Methods of measuring exosomes using intrinsic fluorescenceLONZA SALES AG·Filed 2022·Granted Dec 3, 2024·0 cites·14 claims
- 2276US2023293646A1Methods and compositions for treating lipoprotein-related diseasesCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 2376US2023322901A1Recombinant factor viii proteinsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2476US2025228975A1Methods and compositions for treating lipoprotein-related diseasesCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 2575US2024083975A1Thrombin cleavable linker with xten and its uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2675US2025228964A1Preparation of therapeutic exosomes using membrane proteinsLONZA SALES AG·Filed 2025·Application pending·0 cites
- 2775US2023322900A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2875US2023019286A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2974US2024000944A1Compositions of engineered exosomes and methods of loading luminal exosomes pay-loadsLONZA SALES AG·Filed 2022·Application pending·0 cites
- 3071US10947269B2Purification of chimeric FVIII moleculesBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Mar 16, 2021·2 cites·11 claims
- 3170US2022275057A1Factor viii chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3270US2022056108A1Factor viii complex with xten and von willebrand factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3369US2025289869A1Factor viii chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3469US2019315835A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3568US2022106383A1Thrombin cleavable linker with xten and its uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3667US11685771B2Recombinant factor VIII proteinsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Jun 27, 2023·0 cites·13 claims
- 3767US2015038421A1Factor viii compositions and methods of making and using sameAMUNIX OPERATING INC·Filed 2014·Application pending·0 cites
- 3867US2024342260A1Tissue-directed antibodies and methods of using the sameZAG BIO INC·Filed 2024·Application pending·0 cites
- 3964US2019151456A1Compositions of Engineered Exosomes and Methods of Loading Luminal Exosome PayloadsCODIAK BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 4064US2016376344A1Factor viii compositions and methods of making and using sameAMUNIX OPERATING INC·Filed 2016·Application pending·0 cites
- 4162US2020347112A1Compositions of engineered exosomes and methods of loading luminal exosomes pay-loadsCODIAK BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 4260US2013017997A1Factor VIII Compositions and Methods of Making and Using SameAMUNIX OPERATING INC·Filed 2012·Application pending·0 cites
- 4359US2021032616A1Factor ix fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4459US2020025685A1Methods of measuring exosomes using intrinsic fluorescenceCODIAK BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 4558US2020087379A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4657US2016251408A1Thrombin cleavable linker with xten and its uses thereofBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 4750US2022017907A1Engineered extracellular vesicles and uses thereofCODIAK BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 4848US2016130361A1Anti-factor viii antibodies or uses thereofBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 4946US2016311885A1Recombinant factor viii proteinsBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 5045US2021290556A1Methods of suppressing delivery of exosomes to liver and spleenCODIAK BIOSCIENCES INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Kulman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →